Jane Street Group LLC lowered its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 27.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 21,624 shares of the company's stock after selling 8,001 shares during the period. Jane Street Group LLC's holdings in Henry Schein were worth $1,576,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the business. Stifel Financial Corp lifted its stake in shares of Henry Schein by 1.2% in the third quarter. Stifel Financial Corp now owns 1,122,455 shares of the company's stock worth $81,827,000 after acquiring an additional 13,180 shares during the period. Quantinno Capital Management LP raised its holdings in Henry Schein by 2.8% during the 3rd quarter. Quantinno Capital Management LP now owns 58,533 shares of the company's stock worth $4,267,000 after purchasing an additional 1,591 shares during the last quarter. Investment Management Corp of Ontario acquired a new position in shares of Henry Schein in the 3rd quarter worth approximately $309,000. Holocene Advisors LP bought a new stake in shares of Henry Schein in the 3rd quarter valued at $58,319,000. Finally, Southpoint Capital Advisors LP boosted its stake in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.
Insider Activity at Henry Schein
In other news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.14% of the stock is owned by insiders.
Analysts Set New Price Targets
HSIC has been the topic of several recent analyst reports. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Barrington Research restated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 target price for the company. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and an average target price of $78.89.
View Our Latest Stock Analysis on Henry Schein
Henry Schein Stock Down 0.8 %
Henry Schein stock traded down $0.55 during mid-day trading on Friday, reaching $70.42. The stock had a trading volume of 501,169 shares, compared to its average volume of 1,403,086. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock's 50-day simple moving average is $72.30 and its 200-day simple moving average is $70.16. The firm has a market capitalization of $8.78 billion, a PE ratio of 28.98, a price-to-earnings-growth ratio of 2.31 and a beta of 0.87.
Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm posted $1.32 EPS. Henry Schein's revenue was up .4% compared to the same quarter last year. On average, sell-side analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.
Henry Schein Company Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Recommended Stories
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.